Companies that buy crypto are seeing big stock moves — and some of those moves happened before the news. A report by Fortune has disclosed that several firms which announced large purchases of cryptocurrency also saw sharp stock gains in the days just before their public announcements. That timing has raised red flags for traders, […]Companies that buy crypto are seeing big stock moves — and some of those moves happened before the news. A report by Fortune has disclosed that several firms which announced large purchases of cryptocurrency also saw sharp stock gains in the days just before their public announcements. That timing has raised red flags for traders, […]

Insider Trading Suspicions Mount As Crypto Treasuries Balloon – Report

Companies that buy crypto are seeing big stock moves — and some of those moves happened before the news.

A report by Fortune has disclosed that several firms which announced large purchases of cryptocurrency also saw sharp stock gains in the days just before their public announcements.

That timing has raised red flags for traders, regulators and investors who say those price jumps look like classic front-running — trading on material non-public information.

Suspicious Preannouncement Jumps

According to the report, MEI Pharma’s stock nearly doubled just before it revealed a $100 million purchase of Litecoin.

SharpLink’s shares rose from $3 to $6 in the three trading days before announcing it would add $425 million in Ethereum to its balance sheet.

Mill City Ventures’ stock more than tripled in the two days before it announced a crypto-related fundraise. No new SEC filings, press releases or social chatter were linked to those moves. So the pattern is hard to ignore.

On Crypto, Roadshows & Information Leakage

Based on the report, a common thread appears to be the roadshow — the private meetings where companies pitch deals to selected investors before an announcement.

Roadshows can put many people in a position to hear sensitive plans. When those meetings line up with suspicious stock pops, researchers and executives say information leakage is the likely cause.

Some analysts have likened the behavior to the same sort of insider trading that often shows up around takeover attempts. One academic study even found that many illegal insider trading cases are tied to takeover news that leaks before it is made public.

What The Law Says

US law bans trading on material non-public information. That ban covers company insiders and anyone else who was “wall-crossed” — that is, given confidential details under the condition they keep it private.

Proving who traded on the tip is not always easy, and identifying the specific source of a leak can be complex. But sharp, unexplained price moves right before an announcement often line up with behavior regulators investigate.

Companies Try New Steps

Some firms are taking steps to tighten the window when information might leak. CEA Industries and Verb Technology have changed roadshow tactics.

Instead of giving out a ticker right away, they wait until after market close on a Friday and then make the public announcement on Monday.

That shortens the time anyone has to trade on inside information. It is a practical fix, even if it cannot stop all leaks.

What Investors Should Watch

Short-term spikes without public news deserve caution. Sudden moves that line up with later big corporate actions can mean insiders had a heads-up.

Retail traders who jump into these stocks risk being burned if the market corrects after the announcement or if regulators later intervene.

Transparency and clearer controls on preannouncement briefings are being called for by market watchers who want a fairer playing field.

Featured image from Getty Images, chart from TradingView

Market Opportunity
GAINS Logo
GAINS Price(GAINS)
$0.01383
$0.01383$0.01383
+0.87%
USD
GAINS (GAINS) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Vitalik Buterin Reveals Ethereum’s Bold Plan to Stay Quantum-Secure and Simple!

Vitalik Buterin Reveals Ethereum’s Bold Plan to Stay Quantum-Secure and Simple!

Buterin unveils Ethereum’s strategy to tackle quantum security challenges ahead. Ethereum focuses on simplifying architecture while boosting security for users. Ethereum’s market stability grows as Buterin’s roadmap gains investor confidence. Ethereum founder Vitalik Buterin has unveiled his long-term vision for the blockchain, focusing on making Ethereum quantum-secure while maintaining its simplicity for users. Buterin presented his roadmap at the Japanese Developer Conference, and splits the future of Ethereum into three phases: short-term, mid-term, and long-term. Buterin’s most ambitious goal for Ethereum is to safeguard the blockchain against the threats posed by quantum computing.  The danger of such future developments is that the future may call into question the cryptographic security of most blockchain systems, and Ethereum will be able to remain ahead thanks to more sophisticated mathematical techniques to ensure the safety and integrity of its protocols. Buterin is committed to ensuring that Ethereum evolves in a way that not only meets today’s security challenges but also prepares for the unknowns of tomorrow. Also Read: Ethereum Giant The Ether Machine Takes Major Step Toward Going Public! However, in spite of such high ambitions, Buterin insisted that Ethereum also needed to simplify its architecture. An important aspect of this vision is to remove unnecessary complexity and make Ethereum more accessible and maintainable without losing its strong security capabilities. Security and simplicity form the core of Buterin’s strategy, as they guarantee that the users of Ethereum experience both security and smooth processes. Focus on Speed and Efficiency in the Short-Term In the short term, Buterin aims to enhance Ethereum’s transaction efficiency, a crucial step toward improving scalability and reducing transaction costs. These advantages are attributed to the fact that, within the mid-term, Ethereum is planning to enhance the speed of transactions in layer-2 networks. According to Butterin, this is part of Ethereum’s expansion, particularly because there is still more need to use blockchain technology to date. The other important aspect of Ethereum’s development is the layer-2 solutions. Buterin supports an approach in which the layer-2 networks are dependent on layer-1 to perform some essential tasks like data security, proof, and censorship resistance. This will enable the layer-2 systems of Ethereum to be concerned with verifying and sequencing transactions, which will improve the overall speed and efficiency of the network. Ethereum’s Market Stability Reflects Confidence in Long-Term Strategy Ethereum’s market performance has remained solid, with the cryptocurrency holding steady above $4,000. Currently priced at $4,492.15, Ethereum has experienced a slight 0.93% increase over the last 24 hours, while its trading volume surged by 8.72%, reaching $34.14 billion. These figures point to growing investor confidence in Ethereum’s long-term vision. The crypto community remains optimistic about Ethereum’s future, with many predicting the price could rise to $5,500 by mid-October. Buterin’s clear, forward-thinking strategy continues to build trust in Ethereum as one of the most secure and scalable blockchain platforms in the market. Also Read: Whales Dump 200 Million XRP in Just 2 Weeks – Is XRP’s Price on the Verge of Collapse? The post Vitalik Buterin Reveals Ethereum’s Bold Plan to Stay Quantum-Secure and Simple! appeared first on 36Crypto.
Share
Coinstats2025/09/18 01:22
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26